Abstract:Schizophrenia is a chronic, disabling neuropsychiatric disorder with complex genetic origins. The development of strategies for genome manipulation in rodents provides a platform for understanding the pathogenic role of genes and for testing novel therapeutic agents. Neuregulin 1 (NRG1), a critical developmental neurotrophin, is associated with schizophrenia. The NRG1 gene undergoes extensive alternative splicing and, to date, little is known about the neurobiology of a novel NRG1 isoform, NRG1-IV, which is increased in the brains of individuals with schizophrenia and associated with genetic risk variation. Here, we developed a transgenic mouse model (NRG1-IV/NSE-tTA) in which human NRG1-IV is selectively overexpressed in a neuronal specific manner. Using a combination of molecular, biochemical, electrophysiological, and behavioral analyses, we demonstrate that NRG1-IV/NSE-tTA mice exhibit abnormal behaviors relevant to schizophrenia, including impaired sensorimotor gating, discrimination memory, and social behaviors. These neurobehavioral phenotypes are accompanied by increases in cortical expression of the NRG1 receptor, ErbB4 and the downstream signaling target, PIK3-p110δ, along with disrupted dendritic development, synaptic pathology, and altered prefrontal cortical excitatory-inhibitory balance. Pharmacological inhibition of p110δ reversed sensorimotor gating and cognitive deficits. These data demonstrate a novel role for NRG1-IV in learning, memory, and neural circuit formation and a potential neurobiological mechanism for schizophrenia risk; show that deficits are pharmacologically reversible in adulthood; and further highlight p110δ as a target for antipsychotic drug development. Significance statement: Schizophrenia is a disabling psychiatric disorder with neurodevelopmental origins. Genes that increase risk for schizophrenia have been identified. Understanding how these genes affect brain development and function is necessary. This work is the first report of a newly generated humanized transgenic mouse model engineered to express human NRG1-IV, an isoform of the NRG1 (Neuregulin 1) gene that is increased in the brains of patients with schizophrenia in association with genetic risk. Using behavioral neuroscience, molecular biology, electrophysiology, and pharmacology, we identify a role for NRG1-IV in learning, memory, and cognition and determine that this relates to brain excitatory-inhibitory balance and changes in ErbB4/PI3K/AKT signaling. Moreover, the study further highlights the potential of targeting the PI3K pathway for the treatment of schizophrenia.

Genetic recovery of ErbB4 in adulthood partially restores brain functions in null mice.

The Protective Role Of Neuregulin1-Erbb4 Signaling In A Chronic Social Defeat Stress Model

Brain-specific Ablation of Efr3a Promotes Adult Hippocampal Neurogenesis Via the Brain-Derived Neurotrophic Factor Pathway.

Endothelial ErbB4 Deficit Induces Alterations in Exploratory Behavior and Brain Energy Metabolism in Mice.

F206. A TRANSLATIONAL STUDY OF BEHAVIOR, BRAIN STRUCTURE AND GENE PATHWAY IN ERBB4 KNOCKOUT MICE AND FIRST-EPISODE TREATMENT-NAïVE PATIENTS WITH SCHIZOPHRENIA

ErbB4 in parvalbumin-positive interneurons is critical for neuregulin 1 regulation of long-term potentiation

ErbB4 Deficiency Exacerbates Olfactory Dysfunction in an Early-Stage Alzheimer’s Disease Mouse Model

Development of GABA Circuitry of Fast-Spiking Basket Interneurons in the Medial Prefrontal Cortex of Erbb4-Mutant Mice.

Neuregulin 1 Regulates Pyramidal Neuron Activity Via ErbB4 in Parvalbumin-Positive Interneurons

NRG1–ErbB4 Signaling Promotes Functional Recovery in a Murine Model of Traumatic Brain Injury Via Regulation of GABA Release

Maintenance of GABAergic Activity by Neuregulin 1-Erbb4 in Amygdala for Fear Memory.

ErbB4 Promotes Inhibitory Synapse Formation by Cell Adhesion, Independent of Its Kinase Activity

Expressions of Neuregulin 1βand ErbB4 in Prefrontal Cortex and Hippocampus of a Rat Schizophrenia Model Induced by Chronic MK-801 Administration

Reversal of Behavioral Deficits and Synaptic Dysfunction in Mice Overexpressing Neuregulin 1

Behavioral, Neurophysiological, and Synaptic Impairment in a Transgenic Neuregulin1 (NRG1-IV) Murine Schizophrenia Model

Neuregulin 1 Promotes Excitatory Synapse Development and Function in Gabaergic Interneurons

GABAergic Abnormalities Associated with Sensorimotor Cortico-striatal Community Structural Deficits in ErbB4 Knockout Mice and First-Episode Treatment-Naïve Patients with Schizophrenia

NEGR1 Modulates Mouse Affective Discrimination by Regulating Adult Olfactory Neurogenesis

Aberrant outputs of cerebellar nuclei and targeted rescue of social deficits in an autism mouse model

Reversible Overexpression of Bace1-Cleaved Neuregulin-1 N-terminal Fragment Induces Schizophrenia-Like Phenotypes in Mice.

Retina restored and brain abnormalities ameliorated by single-copy knock-in of human NR2E1 in null mice